Where does Viventia BIO Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Viventia BIO Inc. ranks #38,248 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Viventia BIO Inc. hold?

Viventia BIO Inc. holds 7 US utility patents granted between 2015 and 2020, spanning 9 technology areas.

What is Viventia BIO Inc.'s Innovation Score?

Viventia BIO Inc. has an Innovation Score of 28.4 out of 100 (27th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Viventia BIO Inc. focus on?

Viventia BIO Inc.'s top technology area is C07K (Peptides) with 7 patents. Grants appear in 9 CPC subclasses total.

Is Viventia BIO Inc.'s patent grant rate increasing or decreasing?

Viventia BIO Inc.'s recent grant velocity is -60% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Viventia BIO Inc.'s patents?

Viventia BIO Inc.'s patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Viventia BIO Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Viventia BIO Inc.

USPTO PatentsView assignee record - 7 granted patents across 9 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Viventia ranks #38,248 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 9 technology areas.

#38,248
of 49,997 US assignees by volume: 27th percentile
by Innovation Score (28.4/100): 17.7
avg claims per patent: -60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R38248 · Foreign Corporation #38,248 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
LOWER-Q #38,248/49,997
PHOTO-FINISH Vista Innotech
CPC-NARROW C07K · 9 areas
INNOV-THIN 28.4/100
CLAIMS-RICH 17.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vista Innotech Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Viventia BIO · this assignee

28
3D Lighting… · lowest

7

What this shows Viventia's Innovation Score is 28.4/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Viventia's grants concentrate

Viventia BIO Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2017. By volume, Viventia sits between Vista Innotech Limited and Vlaar Innovations B.V..

Vista Innotech

7
Vista Research Gr…

7
Vitrolabs

7
Vivabiocell S P A

7
Viveo Labs

7
Viveve

7
VK Integrated Sys…

7
Vlaar Innovations…

7
Viventia BIO ◀

7

What this shows Viventia holds 7 patents at rank #38,166, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Viventia

By rank, the assignees closest to #38,166 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Viventia's primary technology class.

Viventia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Viventia BIO Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	57.1%
2017	1	14.3%
2020	2	28.6%

Which technologies does Viventia BIO Inc. patent most?

C07K - Peptides 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C12Y - Enzymes 1

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#38,248

of 49,997 tracked assignees

Innovation Score

28.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Viventia BIO Inc.'s patent record in context - here's where to go next.

Viventia BIO Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #38,248 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Viventia BIO Inc. against Vista Innotech Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.